ABSTRACT
The fungal pathogen Cryptococcus neoformans (C. neoformans) forms yeast cells of different sizes and morphological characteristics during infection. These features are usually not seen in standard laboratory in vitro conditions. Here, we describe in vivo cell morphologies when C. neoformans is grown in human plasma-like medium at 37°C, 5% CO2. We observed mixed-size populations of cells less than 1 µm up to 16.8 µm in cell diameter, increased capsule size, high chitin, and DNA content in larger cells. Our findings show that serum is not required for human plasma-like medium (HPLM)-induced C. neoformans cellular heterogeneity. Thus, this new method offers an opportunity to investigate factors of C. neoformans that mediate pathogenesis or host–pathogen interactions in a physiologically relevant setting.
IMPORTANCE
We provide a description of new in vitro culture condition using the human plasma-like medium that supports the formation of the full range of in vivo cell morphologies of C. neoformans.
KEYWORDS: Cryptococcus neoformans, cell morphology, HPLM, titan cells
OBSERVATION
The fungal pathogen, Cryptococcus neoformans, forms yeast cells of different sizes and morphological characteristics in vivo. Some of these dynamic cell populations include typical sized yeasts (5–7 μm), enlarged cells referred to as titan cells (> 10 µm), and small cells (less than 5 µm) that include micro cells, drop cells, seed cells and titanides (1–4). In contrast to in vivo conditions where significant size heterogeneity exists, C. neoformans grown under nutrient rich conditions in vitro predominantly produce typical sized yeast cells with a uniform morphology. Most in vitro studies on C. neoformans have used these homogenous cell populations, which, although convenient, do not represent the broad range of cellular morphologies present during infection, and therefore may lead to inaccurate conclusions about factors that mediate C. neoformans host–pathogen interactions and pathogenesis.
In 2018, three protocols for the production of titan cells in vitro were described (4–6). The factors found to induce the formation of titan cells include (i) low nutrients, hypoxia, low pH, and continuous shaking (5); (ii) low nutrients, neutral pH, and presence of serum and azide in static conditions with a CO2-enriched atmosphere (6); and (iii) low nutrients and presence of serum in static conditions with a CO2-enriched atmosphere (4). Although there are differences between these three protocols, there are also common themes such as growth under low nutrients, oxygen limitation, and low cell density conditions.
Here, we describe new in vitro conditions that induce the formation of cell morphologies, which mimic the diversity of cell morphologies observed in vivo. To induce the formation of in vivo like Cryptococcus cell morphologies, the wild-type H99 strain was used. Overnight cultures in nutrient-rich yeast extract-peptone-dextrose (YPD) were inoculated into the “human plasma-like medium” (HPLM) and then incubated at 37°C, 5% CO2. HPLM is a relatively new culture medium that was developed using salts and polar metabolites similar to those present in the adult human plasma (7). We observed that Cryptococcus can grow and multiply in HPLM medium. Microscopic observation of cells grown in HPLM shows a population of cells with sizes ranging from small cells of less than 1 µm to large cells up to 16.8 µm in cell diameter (Fig. 1A through C). Using previously described cell body size (diameter) measurements, C. neoformans cells were divided into three sub-populations: titan cells (>10 µm), normal-sized yeasts (5–9 μm), and smaller cells (<4 µm). We observed a mixture of all three cell sub-populations in our cultures (Fig. 1A through C). Similar to previous observations, low cell density induced more cells with a diameter of more than 10 microns when compared to high cell density inocula at 48 and 168 h of incubation (Fig. 1B and C, respectively). We also tested strains known to have defects in titan cell formation in vivo and in vitro, the rim101Δ and gpr4Δ/gpr5Δ mutants (8). Our results show that these two mutants had defects in large cell formation (>10 µm) in HPLM (Fig. 1D). In vivo titan cells are polyploid and have an increased chitin content. Therefore, we used flow cytometry to examine the DNA and cell-wall chitin content after staining with propidium iodide (PI) and calcofluor white (CFW), respectively. We analyzed Cryptococcus grown in HPLM and nutrient rich YPD (control). Typical 5–7 μm cells in YPD had 1C and 2C DNA contents (population 1, Fig. 1E). Similar sized cells (population 1) from HPLM-grown cells also had a majority of 1C and, to a lesser extent, 2C DNA content. Notably, a smaller size population of cells was also observed that had varying side scatter properties, suggestive of cellular diversity (population 6, Fig. 1E). This unique population observed in HPLM was predominantly comprised of cells with 1C DNA content. Consistent with published reports (5, 9), the large cells (populations 4 and 5) had higher DNA content that was >2C (Fig. 1E). Similarly, the large cells (> 10 µm) had increased cell-wall chitin content compared to the typical sized and small cells in HPLM (Fig. 1F and G) as previously described for in vivo titan cells (5, 10).
Fig 1.

Cryptococcus neoformans forms in vivo-like morphologies in HPLM at 37°C, 5% CO2. C. neoformans H99 and various mutant strains were grown overnight in YPD at 30°C with shaking (200 rpm), then washed twice with sterile water, and counted with hemocytometer. Various inoculum concentrations were added to six well plates containing HPLM, and incubated at 37°C, 5% CO2 for 48 h or 168 h. After incubation, C. neoformans cells were analyzed for their cell body (diameter), capsule sizes, DNA content, and chitin content. (A) C. neoformans cells were fixed with formaldehyde, suspended in India ink, and imaged on an Olympus CKX53 microscope. (B and C) Cell diameters were measured using ImageJ at 48 h (B) and 168 h (C). Data presented are representative of three biological replicates with at least 300 cells. (D) Cell size of mutants with defects in titan cell formation. 104 cells/ml was cultured in HPLM as described above. Data presented are representative of four biological replicates with at least 300 cells measured. ***P < 0.001, ****P < 0.0001 (Mann–Whitney test). (E) C. neoformans H99 cells were grown in YPD or HPLM for 48 h, washed in cold sterile water, fixed with 80% methanol, and stained with 50 µg/mL PI for 30 min. DNA content was measured using flow cytometry for populations 1–6. (F and G) To measure the chitin content, 106 cells/mL were stained with 25 µg/mL Calcofluor white for 5 minutes, washed, and then analyzed by imaging flow cytometry. Calcofluor white (for chitin content) stained cells were analyzed by imaging flow cytometer. Data presented are from 8,544 singlets. (H) Diagram of capsule radius measurement. (I-J) Capsule thickness/radius of C. neoformans H99 after 48 h (I) and 168 h (J) of incubation in HPLM. Data presented are representative of four biological replicates with at least 160 cells measured. (K) Capsule thickness of mutants with defects in capsule formation. Cells (104 cells/mL) were incubated in HPLM, and data presented are representative of three biological replicates with at least 100 cells measured. The grey line in figures represents the median. The dotted line at Y-axis represents the 10 µm cut-off, and the percentage of all cell subpopulations are presented in the tables below the graphs (B and C) or next to the graphs (D). DNA: deoxyribonucleic acid, PI: propidium iodide, YPD: yeast extract-peptone-dextrose, HPLM: human plasma-like medium.
In addition to various cell sizes, cells grown in HPLM had a large capsule (Fig. 1A and H). In HPLM, the capsule radius varied between 1.6 and 13.5 µm (median 6.3) in titan cells and 0.6 to 12.8 µm (median 5.4) in non-titan cells (Fig. 1I and J). This is bigger than previously described in vitro cells that had a median capsule radius of 4.8 µm in titan and 2.7 µm in typical cells in vitro (5). Interestingly, some HPLM-grown cells displayed capsule sizes up to 13.5 µm, which is close to sizes observed for in vivo titan cells (14.8 µm) (5). Interestingly, when cell body diameter was plotted against capsule size, we observed that even non-titan cells have larger capsules while some of the titan cells had smaller capsules, further demonstrating the phenotypic heterogeneity of cells grown in HPLM (Fig. S1). Moreover, in head-to-head comparison between HPLM and RPMI medium, Dulbecco’s modified Eagle medium (DMEM), or YPD, only RPMI induced larger cells (>10 µm) similar to HPLM but remarkably only HPLM induced larger capsules (Fig. S2). Mutants with known defects in capsule formation (cap59Δ and cap67Δ) (11, 12) showed small to no capsule formation in HPLM (Fig. 1K). These findings show that the large cells formed in HPLM possess the characteristics of in vivo titan cells.
Small C. neoformans cells were previously characterized depending on various morphological factors, and have been designated by multiple names including micro cells (~1 µm) (13), titanides (oval, metabolically active with a thin cell wall) (4), drop cells (metabolically inactive with a thick cell wall) (14), or seed cells (similar to titanides but have increased mannose exposure and are seen in cultures devoid of titan cells) (3). It is not known whether all these different small cells are present at the same time during infection. Based on the varying side scatter properties of these small cells, we hypothesize that the small cell population generated in HPLM contains a mixture of small cell morphologies.
Serum has been previously described to be an inducer of titan cell formation in vitro (4, 6). We supplemented the HPLM medium with serum to determine whether it would enhance the production of titan cells. C. neoformans grew slowly in HLPM alone (Fig. 2A) contrary to the fast growth observed in HPLM supplemented with 10% fetal bovine serum (FBS) (Fig. 2B). There was also an increase in the number of titan cells in the presence of FBS, both at 48 h (Fig. 2C) and 168 h of incubation (Fig. 2D). For example, titan cells (>10 µm) represented 35.4% of the whole population at 168 h in the presence of serum, while they were 21% in HPLM alone when the initial inoculum was 103 cells (Fig. 1C and 2D). Mutants with defects in titan cell formation behaved similarly in the presence and absence of serum (Fig. 1D and 2E). DNA content was also similar in both HPLM and HPLM supplemented with 10% FBS (Fig. 2F, overlaid on HLPM alone). In addition, the capsule sizes were comparable in HLPM or HPLM supplemented with serum (Fig. 2H through J). These data show that the presence of serum provided a boost in C. neoformans-titan cell formation, but HPLM alone was sufficient to induce cellular heterogeneity similar to that observed in vivo. Statistical analyses comparing the cell body and capsules sizes of cells grown in HPLM with and without serum are presented in the supplemental material (Tables S1 and S2).
Fig 2.

Serum is dispensable for HPLM-induced Cryptococcus neoformans cellular heterogeneity. C. neoformans H99 and various mutant strains were grown overnight in YPD at 30°C with shaking (200 rpm), then washed twice with sterile water, and counted with hemocytometer. Various inoculum concentrations were added to six well plates containing HPLM supplemented with 10% FBS, and incubated at 37°C, 5% CO2 for 48 h or 168 h. After incubation, C. neoformans cells were analyzed for their cell body (diameter), capsule sizes, DNA content, and chitin content. (A and B) Growth curve of C. neoformans H99 in HPLM (A) and HPLM supplemented with FBS (B). Optical density (OD600) was read at 0, 24, 48, 72, 96, and 168 h of incubation. (C and D) Cell body sizes of C. neoformans H99 in HPLM supplemented with FBS at 48 h (C) and 168 h (D) of incubation. Data presented are representative of three biological replicates with at least 300 cells. (E) Cell body sizes of mutants with defects in titan cell formation at 48 h of incubation. Data presented are representative of four biological replicates with at least 300 cells measured. ****P < 0.0001 (Mann–Whitney test) (F) DNA content of H99 cells grown in HPLM (red line, overlaid Fig. 1E) and HPLM supplemented with 10% FBS (blue background). (G) To measure chitin content, 106 cells/mL was stained with 25 µg/mL Calcofluor white for 5 minutes, washed, and then analyzed by imaging flow cytometry. (H and I) Capsule thickness (radius) of H99 cells grown in HPLM and 10%FBS at 48 h (H) and 168 h of incubation (I). Data presented are representative of four biological replicates with at least 160 cells measured. (J) Capsule thickness of mutants with defect in the capsule formation grown in HPLM supplemented with FBS at 48 h incubation. Data presented are representative of three biological replicates with at least 100 cells measured. The grey line in figures represents the median. The dotted line at Y-axis represents the 10 µm cutoff, and the percentage of all cell subpopulations is presented in tables below the graphs (C and D) or next to the graphs (E). DNA: deoxyribonucleic acid, FBS: fetal bovine serum, PI: propidium iodide, HPLM: human plasma-like medium.
Collectively, the results presented here show that HPLM, a medium that more closely resembles the human plasma, which was incubated at 37°C with 5% CO2, can be used to induce the diversity of C. neoformans cell morphologies observed in vivo. HPLM has been used for immunological studies where it induced a different transcriptional response in human primary T-cells and improved their activation after antigen stimulation (15). To our knowledge, HPLM has not been used to grow fungal pathogens and we show, for the first time, that C. neoformans grow and differentiate into in vivo cell morphologies in this medium. Thus, HPLM is a great option to use in experiments investigating C. neoformans pathogenesis, specifically host-Cryptococcus interactions, as it can be used to culture both the fungus and the host immune cells. For example, HPLM is the optimal growth medium when co-culturing C. neoformans with human primary T-cells in vitro. Future work should focus on identifying how this media influences Cryptococcus gene expression that leads to the formation of different cell morphologies in C. neoformans and other members of the Cryptococcus species complex.
ACKNOWLEDGMENTS
We thank Prof Kirsten Nielsen for providing us with C. neoformans strains used in this study. We also thank Prof Neil Gow, Ms Marina Yoder, and Prof Kirsten Nielsen for the helpful feedback on the manuscript.
L.M. is supported by the Academy of Medical Sciences/the Wellcome Trust/ the Government Department of Business, Energy and Industrial Strategy/the British Heart Foundation/Diabetes UK/Global Challenges Research Fund Springboard Award [SBF006\1142]. O.R. is supported by the MRC Doctoral training Grant MR/W502649/1. I.M.D. is supported through fundings from the Wellcome Trust (102705, 217163). E.G.M., O.R., I.M.D., and L.M. are also supported by the Medical Research Council Centre for Medical Mycology at The University of Exeter (MR/N006364/2 and MR/V033417/1).
L.M. and I.M.D. conceived the study, performed most experiments, interpreted data and wrote the manuscript. E.G.M., O.R. and R.F. performed experiments and analyzed the data. L.M., I.M.D., and R.F. wrote and edited the manuscript.
Contributor Information
Ivy M. Dambuza, Email: i.m.dambuza@exeter.ac.uk.
Liliane Mukaremera, Email: l.mukaremera@exeter.ac.uk.
Teresa R. O'Meara, University of Michigan Michigan Medicine, Ann Arbor, Michigan, USA
SUPPLEMENTAL MATERIAL
The following material is available online at https://doi.org/10.1128/msphere.00281-24.
Supplemental tables and figures.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
REFERENCES
- 1. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F, Heitman J, Dromer F, Nielsen K. 2010. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 6:e1000953. doi: 10.1371/journal.ppat.1000953 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. 2010. Fungal cell gigantism during mammalian infection. PLoS Pathog 6:e1000945. doi: 10.1371/journal.ppat.1000945 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Denham ST, Brammer B, Chung KY, Wambaugh MA, Bednarek JM, Guo L, Moreau CT, Brown JCS. 2022. A dissemination-prone morphotype enhances extrapulmonary organ entry by Cryptococcus neoformans. Cell Host Microbe 30:1382–1400. doi: 10.1016/j.chom.2022.08.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Dambuza IM, Drake T, Chapuis A, Zhou X, Correia J, Taylor-Smith L, LeGrave N, Rasmussen T, Fisher MC, Bicanic T, Harrison TS, Jaspars M, May RC, Brown GD, Yuecel R, MacCallum DM, Ballou ER. 2018. The Cryptococcus neoformans titan cell is an inducible and regulated morphotype underlying pathogenesis. PLoS Pathog 14:e1006978. doi: 10.1371/journal.ppat.1006978 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Hommel B, Mukaremera L, Cordero RJB, Coelho C, Desjardins CA, Sturny-Leclère A, Janbon G, Perfect JR, Fraser JA, Casadevall A, Cuomo CA, Dromer F, Nielsen K, Alanio A. 2018. Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators. PLoS Pathog 14:e1006982. doi: 10.1371/journal.ppat.1006982 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Trevijano-Contador N, de Oliveira HC, García-Rodas R, Rossi SA, Llorente I, Zaballos Á, Janbon G, Ariño J, Zaragoza Ó. 2018. Cryptococcus neoformans can form titan-like cells in vitro in response to multiple signals. PLoS Pathog 14:e1007007. doi: 10.1371/journal.ppat.1007007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Cantor JR, Abu-Remaileh M, Kanarek N, Freinkman E, Gao X, Louissaint A, Lewis CA, Sabatini DM. 2017. Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell 169:258–272. doi: 10.1016/j.cell.2017.03.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Okagaki LH, Wang Y, Ballou ER, O’Meara TR, Bahn Y-S, Alspaugh JA, Xue C, Nielsen K. 2011. Cryptococcal titan cell formation is regulated by G-protein signaling in response to multiple stimuli. Eukaryot Cell 10:1306–1316. doi: 10.1128/EC.05179-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Altamirano S, Li Z, Fu MS, Ding M, Fulton SR, Yoder JM, Tran V, Nielsen K. 2021. The cyclin Cln1 controls polyploid titan cell formation following a stress-induced G2 arrest in Cryptococcus. mBio 12:e0250921. doi: 10.1128/mBio.02509-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Wiesner DL, Specht CA, Lee CK, Smith KD, Mukaremera L, Lee ST, Lee CG, Elias JA, Nielsen JN, Boulware DR, Bohjanen PR, Jenkins MK, Levitz SM, Nielsen K. 2015. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog 11:e1004701. doi: 10.1371/journal.ppat.1004701 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Jacobson ES, Ayers DJ, Harrell AC, Nicholas CC. 1982. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol 150:1292–1296. doi: 10.1128/jb.150.3.1292-1296.1982 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Chang YC, Kwon-Chung KJ. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14:4912–4919. doi: 10.1128/mcb.14.7.4912-4919.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Feldmesser M, Kress Y, Casadevall A. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology (Reading) 147:2355–2365. doi: 10.1099/00221287-147-8-2355 [DOI] [PubMed] [Google Scholar]
- 14. Alanio A, Vernel-Pauillac F, Sturny-Leclère A, Dromer F. 2015. Cryptococcus neoformans host adaptation: toward biological evidence of dormancy. mBio 6:e02580-14. doi: 10.1128/mBio.02580-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Leney-Greene MA, Boddapati AK, Su HC, Cantor JR, Lenardo MJ. 2020. Human plasma-like medium improves T lymphocyte activation. iScience 23:100759. doi: 10.1016/j.isci.2019.100759 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental tables and figures.
